Short report: Dengue virus and Japanese encephalitis virus epidemiological shifts in Nepal: A case of opposing trends

American Journal of Tropical Medicine and Hygiene

Volumn 88, Issue 4, 2013, Pages 677-680

  Dumre, Shyam P ^a   Shakya, Geeta ^b   Na Bangchang, Kesara ^a   Eursitthichai, Veerachai ^a   Grams, Hans Rudi ^a   Upreti, Senendra R ^b   Ghimire, Prakash ^c   Khagendra, K C ^b   Nisalak, Ananda ^d   Gibbons, Robert V ^d   Fernandez, Stefan ^d  

^a THAMMASAT UNIVERSITY   (Thailand)

^b Minister for Health and Population Nepal   (Nepal)

^c TRIBHUVAN UNIVERSITY   (Nepal)

^d ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; JAPANESE ENCEPHALITIS VACCINE; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; DENGUE; DENGUE VIRUS; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MORTALITY; NEPAL; ADOLESCENT; CHILD; COMMUNICABLE DISEASE; CROSS REACTION; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; MIDDLE AGED; PATHOGENICITY; PRESCHOOL CHILD; STATISTICS; VACCINATION; VERY ELDERLY; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; CROSS REACTIONS; DENGUE; DENGUE VACCINES; DENGUE VIRUS; DISEASE OUTBREAKS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; JAPANESE ENCEPHALITIS VACCINES; MALE; MIDDLE AGED; NEPAL; VACCINATION; YOUNG ADULT;

MLCS; MLOWN;

EID: 84877154150     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0436     Document Type: Article

References (20)

1. Sohn YM, 2000. Japanese encephalitis immunization in South Korea: past, present, and future. Emerg Infect Dis 6: 17-24. (Pubitemid 30126447)
2. Kyle JL, Harris E, 2008. Global spread and persistence of dengue. Annu Rev Microbiol 62: 71-92.
3. WHO, 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: World Health Organization.
4. Gubler DJ, Meltzer M, 1999. Impact of dengue/dengue hemorrhagic fever on the developing world. Adv Virus Res 53: 35-70.
5. EDCD, 2005. Annual Report: 2002 and 2003. Nepal: Epidemiology and Disease Control Division (EDCD), Department of Health Services, Ministry of Health and Population, Kathmandu.
6. Bista MB, Shrestha JM, 2005. Epidemiological situation of Japanese encephalitis in Nepal. JNMA J Nepal Med Assoc 44: 51-56.
7. WHO, 2003. WHO-Recommended Standards for Surveillance of Selected Vaccine-Preventable Diseases. Geneva: World Health Organization.
8. Wierzba TF, Ghimire P, Malla S, Banerjee MK, Shrestha S, Khanal B, Sedai TR, Gibbons RV, 2008. Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy. Am J Trop Med Hyg 78: 1002-1006. (Pubitemid 351967823)
9. Malla S, Thakur GD, Shrestha SK, Banjeree MK, Thapa LB, Gongal G, Ghimire P, Upadhyay BP, Gautam P, Khanal S, Nisaluk A, Jarman RG, Gibbons RV, 2008. Identification of all dengue serotypes in Nepal. Emerg Infect Dis 14: 1669-1670.
10. Pandey BD, Morita K, Khanal SR, Takasaki T, Miyazaki I, Ogawa T, Inoue S, Kurane I, 2008. Dengue virus, Nepal. Emerg Infect Dis 14: 514-515. (Pubitemid 351451412)
11. Malla S, Ghimire P, Dumre S, Khanal SP, Subedi BK, Wierzba TF, 2005. A First Report of Dengue Fever Cases in Nepal. Health Action in Nepal: Health Newsletter. Available at: http://www.who.int/hac/crises/npl/sitreps/2005/Nepal- Health-Action-Issue-III.pdf. Accessed May 1, 2012.
12. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, Puttisri P, Hoke CH, 1989. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 40: 418-427. (Pubitemid 19117542)
13. WHO, 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment and Control. Geneva: World Health Organization.
14. Bista MB, Banerjee MK, Shin SH, Tandan JB, Kim MH, Sohn YM, Ohrr HC, Tang JL, Halstead SB, 2001. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 358: 791-795. (Pubitemid 32868728)
15. Ohrr H, Tandan JB, Sohn YM, Shin SH, Pradhan DP, Halstead SB, 2005. Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. Lancet 366: 1375-1378. (Pubitemid 41443404)
16. Tandan JB, Ohrr H, Sohn YM, Yoksan S, Ji M, Nam CM, Halstead SB, 2007. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine 25: 5041-5045. (Pubitemid 46881266)
17. WHO, 2011. World Health Organization Country Office for Nepal. National Immunization Programme: Routine Immunization. Available at: http://www.nep. searo.who.int/EN/Section4/Section29/Section89.htm. Accessed May 1, 2012.
18. Tripathi P, Kumar R, Tripathi S, Tambe JJ, Venkatesh V, 2008. Descriptive epidemiology of dengue transmission in Uttar Pradesh. Indian Pediatr 45: 315-318. (Pubitemid 351729797)
19. WHO, 2007. Outbreak Investigation in Nepal. South East Asia Regional Office, New Delhi, India: World Health Organization. Available at: http://209.61.208.233/LinkFiles/Dengue-dengue-Nepal.pdf. Accessed May 14, 2012.
20. Gautam I, Dhimal MN, Shrestha SR, Tamrakar AS, 2009. First record of Aedes aegypti (L.) vector of dengue virus from Kathmandu, Nepal. Journal of Natural History Museum 24: 156-164.